NewZ NewZ with a Zeal
The Global Factor XIII Deficiency Treatment Market will be worth US$ 210.3 million in 2023 and has been estimated to grow at a significant CAGR of 5.8% to reach US$ 400.7 Million by 2034.The patients of deficiency of factor XIII
Read more
Related Articles
Check Also
Speedy Tigers brace for tough test Down Under
PETALING JAYA: The youngsters in the national hockey team have shown their capabilities during friendly …
Asia-Pacific private equity shows green shoots of recovery
India and Japan have become hotspots for PE investorsDeal value increased, exits recovered, fund-raising remained …